Stat1 functions as a attenuator of Runx2 in the transcriptional program of osteoblast cytoplasmic differentiation

被引:227
作者
Kim, S
Koga, T [1 ]
Isobe, M
Kern, BE
Yokochi, T
Chin, YE
Karsenty, G
Taniguchi, T
Takayanagi, H
机构
[1] Univ Tokyo, Grad Sch Med, Dept Immunol, Tokyo 1130033, Japan
[2] Univ Tokyo, Fac Med, Tokyo 1130033, Japan
[3] Japan Sci & Technol Corp, JST, Kawaguchi, Saitama 3320012, Japan
[4] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA
[5] Brown Univ, Sch Med, Dept Pathol & Lab Med, Providence, RI 02912 USA
关键词
Stat1; Runx2; osteoblast; bone remodeling;
D O I
10.1101/gad.1119303
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Bone remodeling is central to maintaining the integrity of the skeletal system, wherein the developed bone is constantly renewed by the balanced action of osteoblastic bone formation and osteoclastic bone resorption. In the present study, we demonstrate a novel function of the Stat1 transcription factor in the regulation of bone remodeling. In the bone of the Stat1-deficient mice, excessive osteoclastogenesis is observed, presumably caused by a loss of negative regulation of osteoclast differentiation by interferon (IFN)-beta. However, the bone mass is unexpectedly increased in these mice. This increase is caused by excessive osteoblast differentiation, wherein Stat1 function is independent of IFN signaling. Actually, Stat1 interacts with Runx2 in its latent form in the cytoplasm, thereby inhibiting the nuclear localization of Runx2, an essential transcription factor for osteoblast differentiation. The new function of Stat1 does not require the Tyr 701 that is phosphorylated when Stat1 becomes a transcriptional activator. Our study provides a unique example in which a latent transcription factor attenuates the activity of another transcription factor in the cytoplasm, and reveals a new regulatory mechanism in bone remodeling.
引用
收藏
页码:1979 / 1991
页数:13
相关论文
共 47 条
  • [1] Activation of the Janus kinase/STAT (signal transducer and activator of transcription) signal transduction pathway by interleukin-6-type cytokines promotes osteoblast differentiation
    Bellido, T
    Borba, VZC
    Roberson, P
    Manolagas, SC
    [J]. ENDOCRINOLOGY, 1997, 138 (09) : 3666 - 3676
  • [2] How Stat1 mediates constitutive gene expression: a complex of unphosphorylated Stat1 and IRF1 supports transcription of the LMP2 gene
    Chatterjee-Kishore, M
    Wright, KL
    Ting, JPY
    Stark, GR
    [J]. EMBO JOURNAL, 2000, 19 (15) : 4111 - 4122
  • [3] Bone morphogenetic protein-3 is a negative regulator of bone density
    Daluiski, A
    Engstrand, T
    Bahamonde, ME
    Gamer, LW
    Agius, E
    Stevenson, SL
    Cox, K
    Rosen, V
    Lyons, KM
    [J]. NATURE GENETICS, 2001, 27 (01) : 84 - 88
  • [4] Fibroblast growth factor receptor 3 is a negative regulator of bone growth
    Deng, CX
    WynshawBoris, A
    Zhou, F
    Kuo, A
    Leder, P
    [J]. CELL, 1996, 84 (06) : 911 - 921
  • [5] The osteoblast: A sophisticated fibroblast under central surveillance
    Ducy, P
    Schinke, T
    Karsenty, G
    [J]. SCIENCE, 2000, 289 (5484) : 1501 - 1504
  • [6] Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation
    Ducy, P
    Zhang, R
    Geoffroy, V
    Ridall, AL
    Karsenty, G
    [J]. CELL, 1997, 89 (05) : 747 - 754
  • [7] TGF-beta signalling from cell membrane to nucleus through SMAD proteins
    Heldin, CH
    Miyazono, K
    tenDijke, P
    [J]. NATURE, 1997, 390 (6659) : 465 - 471
  • [8] RUNX transcription factors as key targets of TGF-β superfamily signaling
    Ito, Y
    Miyazono, K
    [J]. CURRENT OPINION IN GENETICS & DEVELOPMENT, 2003, 13 (01) : 43 - 47
  • [9] Javed A, 1999, MOL CELL BIOL, V19, P7491
  • [10] Increased bone formation and osteosclerosis in mice overexpressing the transcription factor Fra-l
    Jochum, W
    David, JP
    Elliott, C
    Wutz, A
    Plenk, H
    Matsuo, K
    Wagner, EF
    [J]. NATURE MEDICINE, 2000, 6 (09) : 980 - 984